Inventor
KATHALA KALYAN
US26 patents
⚠️ This page may combine multiple inventors who share the name “KATHALA KALYAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TRIS PHARMA INC
15 patentsUS10857143B2Dec 8, 2020
Methylphenidate extended release chewable tablet
TRIS PHARMA INC45 citations98
US10507203B2Dec 17, 2019
Methylphenidate extended release chewable tablet
TRIS PHARMA INC42 citations98
US9844545B2Dec 19, 2017
Methylphenidate extended release chewable tablet
TRIS PHARMA INC43 citations98
US9844544B2Dec 19, 2017
Methylphenidate extended release chewable tablet
TRIS PHARMA INC46 citations98
US9545399B2Jan 17, 2017
Methylphenidate extended release chewable tablet
TRIS PHARMA INC50 citations98
US9295642B2Mar 29, 2016
Methylphenidate extended release chewable tablet
TRIS PHARMA INC61 citations98
US9180100B2Nov 10, 2015
Methylphenidate extended release chewable tablet
TRIS PHARMA INC55 citations98
US8999386B2Apr 7, 2015
Methylphenidate extended release chewable tablet
TRIS PHARMA INC56 citations98
US11103494B2Aug 31, 2021
Methylphenidate extended release chewable tablet
TRIS PHARMA INC5 citations84
US11103495B2Aug 31, 2021
Methylphenidate extended release chewable tablet
TRIS PHARMA INC5 citations84
US12076441B2Sep 3, 2024
Extended release amphetamine tablets
TRIS PHARMA INC0 citations62
US11633389B2Apr 25, 2023
Methylphenidate extended release chewable tablet
TRIS PHARMA INC0 citations62
US11590228B1Feb 28, 2023
Extended release amphetamine compositions
TRIS PHARMA INC1 citations62
US11590081B1Feb 28, 2023
Extended release amphetamine tablets
TRIS PHARMA INC1 citations62
US12458592B1Nov 4, 2025
Extended release amphetamine tablets
TRIS PHARMA INC0 citations45
TULEX PHARMACEUTICALS INC
8 patentsUS12343372B2Jul 1, 2025
Desmopressin oral compositions
TULEX PHARMACEUTICALS INC2 citations72
US12214010B2Feb 4, 2025
Desmopressin oral compositions
TULEX PHARMACEUTICALS INC2 citations72
US11911362B2Feb 27, 2024
Compositions and methods for treating epilepsy, seizures and other conditions
TULEX PHARMACEUTICALS INC1 citations72
US11826343B2Nov 28, 2023
Compositions and methods for treating epilepsy, seizures and other conditions
TULEX PHARMACEUTICALS INC1 citations72
US11633374B2Apr 25, 2023
Compositions and methods for treating epilepsy, seizures and other conditions
TULEX PHARMACEUTICALS INC2 citations72
US11433046B2Sep 6, 2022
Compositions and methods for treating epilepsy, seizures and other conditions
TULEX PHARMACEUTICALS INC3 citations72
US12290503B2May 6, 2025
Compositions and methods for treating epilepsy, seizures and other conditions
TULEX PHARMACEUTICALS INC0 citations62
US12576125B2Mar 17, 2026
Desmopressin oral compositions
TULEX PHARMACEUTICALS INC0 citations60